MYCOPHENOLATE TEVA 500 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

MYCOPHENOLATE MOFETIL

متاح من:

TEVA ISRAEL LTD

ATC رمز:

L04AA06

الشكل الصيدلاني:

TABLETS

تركيب:

MYCOPHENOLATE MOFETIL 500 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

المجموعة العلاجية:

MYCOPHENOLIC ACID

المجال العلاجي:

MYCOPHENOLIC ACID

الخصائص العلاجية:

Prophylaxis of rejection in renal allograft recepients, in patients receiving allogenic cardiac transplants and in allogenic hepatic transplants.Mycophenolate Teva should be used concomitantly with ciclosporin and corticosteroids.

تاريخ الترخيص:

2014-12-31

نشرة المعلومات

PATIENT PACKAGE INSERT IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is dispensed with
a doctor’s prescription only
MYCOPHENOLATE TEVA 500 MG
TABLETS
COMPOSITION:
Each tablet contains:
Mycophenolate mofetil 500 mg
For information on inactive and allergenic
ingredients, see section 2 “Important information
about some of the ingredients of the medicine”
and section 6 - “Further Information”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE
USING THE MEDICINE. This leaflet contains concise
information about the medicine. If you have further
questions, refer to the doctor or pharmacist.
∙ This medicine has been prescribed for the
treatment of your ailment only. Do not pass it
on to others. It may harm them, even if it seems
to you that their medical condition is similar.
IMPORTANT INFORMATION FOR YOUR REVIEW
∙ Warning: Mycophenolate causes miscarriages
and birth defects. Do not commence treatment
with Mycophenolate Teva in women of child-
bearing age, without a negative pregnancy test
before starting the treatment.
∙ Follow the instructions for contraception that
will be given to you by the attending doctor.
If you did not fully understand the instructions,
consult the doctor again before taking the
medicine.
For further information, see section “Special
warnings regarding use of the medicine”
and section “Pregnancy, contraception and
breastfeeding”.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine Mycophenolate Teva is used, in
combination with cyclosporin and corticosteroids,
to prevent rejection of a transplanted organ in
kidney, heart or liver transplant patients.
THERAPEUTIC GROUP
Immunosuppressants.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
∙ You are allergic to mycophenolate mofetil, to
mycophenolic acid, or to any of the additional
ingredients contained in the medicine (for the
list of inactive ingredients, see section 6 –
“Further information”).
∙ You are a woman of child-bearing age and
you have not undergone a negati